View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
Sponsored by ZETA

Utilization of a Novel kLa Measurement Procedure for Bioreactor Characterization and Optimization to Assist with Compliance of Regulatory Guidelines

Free White Paper

Utilization of a Novel kLa Measurement Procedure for Bioreactor Characterization and Optimization to Assist with Compliance of Regulatory Guidelines

By ZETA

Utilization of a Novel kLa Measurement Procedure for Bioreactor Characterization and Optimization to Assist with Compliance of Regulatory Guidelines

By ZETA
Enter your details to receive the free paper:

CGMP regulations stipulate that sampling and testing of in-process materials and drug products requires control procedures to “be established to monitor the output and to validate the performance of those manufacturing processes that may be responsible for causing variability in the characteristics of in-process material and the drug product”.

According to USFDA guidelines, utilizing validated processes is critical to ensuring a drug is fit for its intended use.

Please download this free white paper to read more.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU